• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型 p53 与基因组不稳定性之间的联系。

Links between mutant p53 and genomic instability.

机构信息

Department of Pathology, Stony Brook University, Stony Brook, New York 11794, USA.

出版信息

J Cell Biochem. 2012 Feb;113(2):433-9. doi: 10.1002/jcb.23400.

DOI:10.1002/jcb.23400
PMID:22006292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4407809/
Abstract

The tumor suppressor p53 has long been known to play a central role in maintaining a stable genome in the face of toxic insults through its role in promoting cell-cycle checkpoints, DNA repair, and apoptosis. However, p53 null cells still retain some function of certain checkpoint and repair processes, reducing the genomic changes that otherwise would occur if these mechanisms were absent. Accumulating evidence suggests that mutant forms of p53 proteins may drastically perturb these residual genome-stabilizing mechanisms through gain-of-function interactions with multiple proteins leading to a higher level of genomic instability than in p53 null cells. This review summarizes the current body of evidence that mutp53 plays a role in promoting various forms of genomic instability and provides an overview of current mechanistic proposals.

摘要

抑癌基因 p53 长期以来一直被认为在应对有毒物质的侵害时,通过促进细胞周期检查点、DNA 修复和细胞凋亡,在维持稳定的基因组方面发挥着核心作用。然而,p53 缺失细胞仍然保留了某些检查点和修复过程的功能,从而减少了如果这些机制缺失时本会发生的基因组变化。越来越多的证据表明,p53 蛋白的突变形式可能通过与多种蛋白的功能获得性相互作用,严重扰乱这些残留的基因组稳定机制,导致比 p53 缺失细胞更高水平的基因组不稳定性。这篇综述总结了目前关于 mutp53 促进各种形式基因组不稳定性的证据,并概述了目前的机制假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e1/4407809/2309629d75d8/nihms653824f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e1/4407809/9919f707ae08/nihms653824f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e1/4407809/2309629d75d8/nihms653824f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e1/4407809/9919f707ae08/nihms653824f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e1/4407809/2309629d75d8/nihms653824f2.jpg

相似文献

1
Links between mutant p53 and genomic instability.突变型 p53 与基因组不稳定性之间的联系。
J Cell Biochem. 2012 Feb;113(2):433-9. doi: 10.1002/jcb.23400.
2
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.p53功能获得性癌症突变体通过使ATM失活诱导基因不稳定。
Nat Cell Biol. 2007 May;9(5):573-80. doi: 10.1038/ncb1571. Epub 2007 Apr 8.
3
The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.p53介导的细胞凋亡作为对基因组不稳定的关键抗肿瘤反应的作用:来自小鼠模型的经验教训。
Mutat Res. 2005 Jan 6;569(1-2):145-57. doi: 10.1016/j.mrfmmm.2004.04.019.
4
A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model.在一种新型的p53基因缺失乳腺上皮细胞模型中,一种功能获得性p53突变体既促进基因组不稳定,又促进细胞存活。
FASEB J. 2000 Nov;14(14):2291-302. doi: 10.1096/fj.00-0128com.
5
A common gain of function of p53 cancer mutants in inducing genetic instability.p53 癌基因突变体诱导遗传不稳定性的常见功能获得。
Oncogene. 2010 Feb 18;29(7):949-56. doi: 10.1038/onc.2009.376. Epub 2009 Nov 2.
6
p53 reactivating small molecule PRIMA‑1/APR‑246 regulates genomic instability in MDA‑MB‑231 cells.p53 激活小分子 PRIMA-1/APR-246 调节 MDA-MB-231 细胞中的基因组不稳定性。
Oncol Rep. 2022 Apr;47(4). doi: 10.3892/or.2022.8296. Epub 2022 Mar 2.
7
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.功能获得性突变型p53蛋白与E2F4协同作用,转录下调RAD17和BRCA1基因表达。
Oncotarget. 2015 Mar 20;6(8):5547-66. doi: 10.18632/oncotarget.2587.
8
Role of the p53 family in stabilizing the genome and preventing polyploidization.p53 家族在稳定基因组和防止多倍体形成中的作用。
Adv Exp Med Biol. 2010;676:73-91. doi: 10.1007/978-1-4419-6199-0_5.
9
Gain-of-function mutant p53 in cancer progression and therapy.抑癌基因 p53 功能获得性突变与癌症的发生发展及治疗
J Mol Cell Biol. 2020 Sep 1;12(9):674-687. doi: 10.1093/jmcb/mjaa040.
10
Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53.辐照诱导表达突变型 p53 的乳腺癌中 p53 杂合性丢失。
Commun Biol. 2019 Nov 27;2:436. doi: 10.1038/s42003-019-0669-y. eCollection 2019.

引用本文的文献

1
Genomic spectra of lymphovascular invasion in breast cancer.乳腺癌中淋巴管浸润的基因组图谱。
Chin J Cancer Res. 2025 Apr 30;37(2):138-153. doi: 10.21147/j.issn.1000-9604.2025.02.02.
2
Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53.避开基因组守护者:当前针对突变型p53的癌症治疗方法
Front Pharmacol. 2025 Jan 29;16:1529483. doi: 10.3389/fphar.2025.1529483. eCollection 2025.
3
Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment.

本文引用的文献

1
p73 in Cancer.癌症中的p73
Genes Cancer. 2011 Apr;2(4):491-502. doi: 10.1177/1947601911408890.
2
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.Pin1/突变 p53 轴促进乳腺癌的侵袭性。
Cancer Cell. 2011 Jul 12;20(1):79-91. doi: 10.1016/j.ccr.2011.06.004.
3
p53 and its mutants in tumor cell migration and invasion.p53 及其突变体在肿瘤细胞迁移和侵袭中的作用。
个性化免疫:基于新抗原的疫苗正在彻底改变肝细胞癌的治疗方式。
Cancers (Basel). 2025 Jan 23;17(3):376. doi: 10.3390/cancers17030376.
4
Use of Oral Rub and Rinse Technique for Oral Cancer Screening: Results from a Community-based Program in an LMIC.使用口腔摩擦和冲洗技术进行口腔癌筛查:来自低收入和中等收入国家一个社区项目的结果
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):91-99. doi: 10.31557/APJCP.2025.26.1.91.
5
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.乳腺癌和卵巢癌中的TP53突变与MDM2多态性:药物和天然化合物的改善作用
Clin Transl Oncol. 2025 Jan 11. doi: 10.1007/s12094-024-03841-6.
6
Mapping the chromothripsis landscape in urothelial carcinoma unravels great intratumoral and intertumoral heterogeneity.绘制尿路上皮癌中的染色体碎裂图谱揭示了肿瘤内和肿瘤间的巨大异质性。
iScience. 2024 Dec 2;28(1):111510. doi: 10.1016/j.isci.2024.111510. eCollection 2025 Jan 17.
7
Sodium arsenite-induced DNA methylation alterations exacerbated by p53 knockout in MCF7 cells.亚砷酸钠诱导的DNA甲基化改变在MCF7细胞中因p53基因敲除而加剧。
Heliyon. 2024 Oct 18;10(21):e39548. doi: 10.1016/j.heliyon.2024.e39548. eCollection 2024 Nov 15.
8
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments.靶向 Polo-like kinase 2 以提高表达突变型 p53 的肿瘤细胞对癌症治疗的敏感性:一种新策略。
J Mol Med (Berl). 2024 Dec;102(12):1485-1501. doi: 10.1007/s00109-024-02499-5. Epub 2024 Oct 31.
9
The Role of Endoplasmic Reticulum Stress on Reducing Recombinant Protein Production in Mammalian Cells.内质网应激在降低哺乳动物细胞中重组蛋白产量方面的作用。
Biochem Eng J. 2024 Oct;210. doi: 10.1016/j.bej.2024.109434. Epub 2024 Jul 20.
10
Extra-appendiceal mucinous neoplasms: A tumour with clinicopathologic similarities to low- and high-grade appendiceal counterpart.阑尾外黏液性肿瘤:一种具有与低级别和高级别阑尾肿瘤相似的临床病理特征的肿瘤。
Hum Pathol. 2024 Jun;148:23-31. doi: 10.1016/j.humpath.2024.04.010. Epub 2024 Apr 25.
J Cell Biol. 2011 Jan 24;192(2):209-18. doi: 10.1083/jcb.201009059.
4
Distant metastasis occurs late during the genetic evolution of pancreatic cancer.远处转移发生在胰腺癌遗传进化的晚期。
Nature. 2010 Oct 28;467(7319):1114-7. doi: 10.1038/nature09515.
5
The patterns and dynamics of genomic instability in metastatic pancreatic cancer.转移性胰腺癌中基因组不稳定性的模式和动态。
Nature. 2010 Oct 28;467(7319):1109-13. doi: 10.1038/nature09460.
6
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.TAp63 通过协调调控 Dicer 和 miRNAs 抑制转移。
Nature. 2010 Oct 21;467(7318):986-90. doi: 10.1038/nature09459.
7
p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.p53 基因突变和缺失对新型多形性横纹肌肉瘤小鼠模型肿瘤发生的影响不同。
J Pathol. 2010 Oct;222(2):129-37. doi: 10.1002/path.2748.
8
Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.干扰 p53 家族网络有助于突变型 p53 在肝细胞癌中获得致癌功能。
Biochem Biophys Res Commun. 2010 Apr 9;394(3):817-23. doi: 10.1016/j.bbrc.2010.03.082. Epub 2010 Mar 15.
9
Mutant p53 drives invasion by promoting integrin recycling.突变型 p53 通过促进整合素循环促进侵袭。
Cell. 2009 Dec 24;139(7):1327-41. doi: 10.1016/j.cell.2009.11.026.
10
When mutants gain new powers: news from the mutant p53 field.当突变体获得新能力时:来自突变型p53领域的消息。
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.